Maven Securities LTD Evolus, Inc. Transaction History

Maven Securities LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.37 - $8.38 $3.01 Million - $4.7 Million	-560,481 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.36 - $13.67 $2.91 Million - $5.41 Million	395,481 Added 239.69%	560,481 $4.27 Million
Q2 2021 Aug 16, 2021	BUY	$8.42 - $13.96 $1.39 Million - $2.3 Million	165,000 New	165,000 $2.09 Million

163

49.1M

453K

14K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $909M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.